DBV DBV Technologies SA

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

                                                       

Information regarding the total number of voting rights and

total number of shares of the Company as of May 30, 2025

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345







Date





Total number of shares Total number of voting rights
05/30/2025





136,973,697











Total gross of voting rights: 136,973,697











Total net* of voting rights: 136,738,528





* Net total = total number of voting rights attached to shares – shares without voting rights

Attachment



EN
04/06/2025

Underlying

DBVDBV Technologies SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DBV Technologies SA

 PRESS RELEASE
Free
DBV DBV Technologie...

Information Regarding the Total Number of Voting Rights and Total Numb...

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025                                                         Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights05/30/2025136,973,697Total gross of voting rights: 136,973,697Total net* of voting rights: 136,738,528 * Net to...

June 4, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Information relative au nombre total des droits de vote et d’actions ...

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 mai 2025                                                                                                                                                                                                                                        Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 mai 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 001041734...

June 4, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies announces the filing of an addendum to the 2024 Unive...

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), today announced today the filing of an addendum to the 2024 Universal Registration Document (the “Addendum”) with the French market authority, “Autorité des Marchés Financiers” (“AMF”). This Addendum provides an update to t...

June 3, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies publie un amendement à son Document d’enregistrement ...

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en phase clinique, annonce le dépôt auprès de l’Autorité des marchés financiers (« AMF ») et la mise à disposition auprès du public d’un amendement à son Document d’enregistrement universel 2024 (« l’Amendement »). Cet Amendement intègre notamment une mise à...

June 3, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Combined General Meeting of June 11, 2025

Combined General Meeting of June 11, 2025 Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), will hold its Combined General Meeting (the “General Meeting”) on June 11, 2025, at 02:00 p.m. CEST (08:00 a.m EST) at the Company’s headquarters located at IRO Building, 107 Avenue de la République, 92320 Châtillon, France. The prelimina...

May 15, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch